128 related articles for article (PubMed ID: 25196375)
1. Short-term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps.
Weng J; Retnakaran R; Ariachery C A; Ji L; Meneghini L; Yang W; Woo JT
Diabetes Metab Res Rev; 2015 Sep; 31(6):537-44. PubMed ID: 25196375
[TBL] [Abstract][Full Text] [Related]
2. Novel Strategies for Inducing Glycemic Remission during the Honeymoon Phase of Type 2 Diabetes.
Retnakaran R
Can J Diabetes; 2015 Dec; 39 Suppl 5():S142-7. PubMed ID: 26653254
[TBL] [Abstract][Full Text] [Related]
3. Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetes.
Xu W; Weng J
J Diabetes; 2013 Sep; 5(3):268-74. PubMed ID: 23551748
[TBL] [Abstract][Full Text] [Related]
4. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
van Raalte DH; Verchere CB
Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
[TBL] [Abstract][Full Text] [Related]
5. HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not?
Reaven GM
Diab Vasc Dis Res; 2009 Apr; 6(2):133-8. PubMed ID: 20368203
[No Abstract] [Full Text] [Related]
6. Intensive insulin therapy in newly diagnosed type 2 diabetes.
Retnakaran R; Drucker DJ
Lancet; 2008 May; 371(9626):1725-6. PubMed ID: 18502278
[No Abstract] [Full Text] [Related]
7. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.
Kramer CK; Zinman B; Retnakaran R
Lancet Diabetes Endocrinol; 2013 Sep; 1(1):28-34. PubMed ID: 24622264
[TBL] [Abstract][Full Text] [Related]
8. Improvement in insulin sensitivity following intensive insulin therapy and association of glucagon with long-term diabetes remission.
Zhang B; Chen YY; Yang ZJ; Wang X; Li GW
J Int Med Res; 2016 Dec; 44(6):1543-1550. PubMed ID: 27834301
[TBL] [Abstract][Full Text] [Related]
9. Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function.
Retnakaran R; Zinman B
Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():161-6. PubMed ID: 22928577
[TBL] [Abstract][Full Text] [Related]
10. [Indications for a favourable effect of intensive insulin therapy for newly-diagnosed type 2 diabetes].
Roep BO; Pijl H
Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2378-80. PubMed ID: 19055134
[TBL] [Abstract][Full Text] [Related]
11. [Insulin pump in type 2 diabetes: B-cell focused treatment].
Picková K; Rušavý Z
Vnitr Lek; 2017; 63(6):441-445. PubMed ID: 28840741
[TBL] [Abstract][Full Text] [Related]
12. Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and type 2 diabetes: Action LADA 9 [corrected].
Juhl CB; Bradley U; Holst JJ; Leslie RD; Yderstraede KB; Hunter S;
Diabet Med; 2014 Aug; 31(8):941-5. PubMed ID: 24628669
[TBL] [Abstract][Full Text] [Related]
13. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
14. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission.
Liu L; Ke W; Wan X; Zhang P; Cao X; Deng W; Li Y
Diabetes Res Clin Pract; 2015 May; 108(2):250-7. PubMed ID: 25765670
[TBL] [Abstract][Full Text] [Related]
15. Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes.
Kramer CK; Choi H; Zinman B; Retnakaran R
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1398-407. PubMed ID: 24129396
[TBL] [Abstract][Full Text] [Related]
16. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus.
Leahy JL; Hirsch IB; Peterson KA; Schneider D
J Clin Endocrinol Metab; 2010 Sep; 95(9):4206-16. PubMed ID: 20739389
[TBL] [Abstract][Full Text] [Related]
17. American Diabetes Association Standards of Medical Care in Diabetes 2017.
Marathe PH; Gao HX; Close KL
J Diabetes; 2017 Apr; 9(4):320-324. PubMed ID: 28070960
[No Abstract] [Full Text] [Related]
18. [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].
Liu SP; Mo H; Liu BL; Tang WL; Deng XG; Su X; Yao L; Lin J; Feng Q; Peng J; Zhou ZG; Li YJ
Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):405-9. PubMed ID: 20646415
[TBL] [Abstract][Full Text] [Related]
19. The end of insulin? A newly discovered hormone could free diabetics from injections.
Park A
Time; 2013 May; 181(18):12. PubMed ID: 23738395
[No Abstract] [Full Text] [Related]
20. beta-cell failure in diabetes and preservation by clinical treatment.
Wajchenberg BL
Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
